Recombinant viral vectors and methods for inducing a heterosubtypic immune response to influenza A viruses

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9463237
SERIAL NO

13982524

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to recombinant viral vectors and methods of using the recombinant viral vectors to induce an immune response to influenza A viruses. The invention provides recombinant viral vectors based, for example, on the non-replicating modified vaccinia virus Ankara. When administered according to methods of the invention, the recombinant viral vectors are designed to be cross-protective and induce heterosubtypic immunity to influenza A viruses.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
RESILIENCE GOVERNMENT SERVICES INC9310 ATHENA CIRCLE LA JOLLA CA 92037

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Barrett, P Noel Klosterneuburg/Weidling, AT 7 43
Ehrlich, Hartmut Vienna, AT 46 206
Falkner, Falko-Günter Orth/Donau, AT 9 44
Hessel, Annett Orth/Donau, AT 3 23
Kreil, Thomas R Klosterneuburg, AT 3 11
Schafer, Birgit Vienna, AT 2 11

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 11, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00